Patrick Ott
MD, PhD
Clinical Director, Melanoma Disease Center
👥Biography 个人简介
Dr. Patrick Ott is a leading expert in cancer neoantigen vaccines and immunotherapy biomarkers at Dana-Farber Cancer Institute. He has led landmark clinical trials combining neoantigen vaccines with PD-1 blockade, demonstrating durable responses in melanoma. His work on RNA-based immune signatures to predict immunotherapy outcomes has opened new avenues for patient selection.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Patrick Ott 的研究动态
Follow Patrick Ott's research updates
留下邮箱，当我们发布与 Patrick Ott（Dana-Farber Cancer Institute / Harvard Medical School）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment